Question | Answer |
Intradermal injection sites include; | 1.The anterior portion of the inferior arm
2.The posterior portion of the superior arm
3.The superior portion of the back
4.The superior thorax |
Intradermal (ID) Tuburculin (TB) skin tests are usually performed on the clients; | Anterior forearm, 2-3 finger length from the antecubital space to a hands-width above the wrist |
The common length of an ID needle is; | 3/8 - 1/2 inch |
The common needle gauge (bore) for intradermal injection is | 25G to 30G |
An ID needle is inserted at a; | 10-15 degree angle with the bevel up (until the bevel disappears) |
A successful ID injection is achieved with the appearance of a; | Bleb / Wheal |
After the ID injection, quickly withdraw the needle, apply pressure to the injection site with a | Sterle 2x2, active the needle safety system, and dispose in a Sharps |
Document the ID injection in the clients chart including; | 1.Date
2.Military Time
3.Drug name
4.Dosage
5.Route
6.Site
7.Client reaction
8.Expiration Date
9.Lot number
10.Manufacture
11.Client education provided |
Intradermal (ID) injections are commonly used for; | 1.Allergy testing
2.TST - Tuberculin skin testing |
Tuberculin (TST) testing AKA | Tine
Mantoux
PPD |
A TST Tuberculin test should be evaluated; | 48 - 72hrs |
A positive TST test occurs when; | 1.15mm induration occurs (standard)
2.5mm induration for clients w/RA or CD
3.10mm induration for; Healthcare workers, diabetics or kidney disease
4.If vesiculation occurs (blisters) |